Huan-Ping Wu

This inventor holds 106 USPTO granted patents and 7 published patent applications, plus 22 CIPO patents and 42 EPO patents, primarily in Biosensor Technology (CPC class G01N27-3274). Top assignees: Ascensia Diabetes Care Holdings Ag, Bayer Healthcare LLC. Active years: 2010-2026.

USPTO Granted Patents = 106 (Patent Applications = 7)

% Patents Active = 99.1

CIPO Patents = 22 (Patent Applications = 9)

EPO Patents = 42 (Patent Applications = 41)

Average Co-Inventor Count = 1.7

ph-index = 11

Forward Citations = 337(Granted Patents)

Forward Citations (Not Self Cited) = 169(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Company Filing History:

57 out of 231

Ascensia Diabetes Care Holdings Ag

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Biosensor

Analyte Concentration

Error Compensation

Continuous Monitoring

Gated Voltammetry

Electrochemical Sensor

Calibration

Signal Processing

Anomaly Detection

Multi-Region Sensors

Rapid-Read Devices

Voltage Modulation

106 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12678072 - Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing (2026-07-14),

2. 12514470 - Biosensor with membrane structure for steady-state and non-steady-state conditions for determining analyte concentrations (2026-01-06),

3. 12465244 - Extracting parameters for analyte concentration determination (2025-11-11),

4. 11988626 - Residual compensation including underfill error (2024-05-21),

5. 11963763 - Methods and apparatus information gathering, error detection and analyte concentration determination during continuous analyte sensing (2024-04-23),

6. 11950904 - Non-steady-state determination of analyte concentration for continuous glucose monitoring by potential modulation (2024-04-09),

7. 11913898 - System error compensation of analyte concentration determinations based on pseudo-reference concentration and signal-based anchor parameters (2024-02-27),

8. 11872035 - Continuous analyte monitoring sensor calibration and measurements by a connection function (2024-01-16),

9. 11737688 - Apparatus and methods of probing sensor operation and/or determining analyte values during continuous analyte sensing (2023-08-29),

10. 11678820 - Methods and apparatus for information gathering, error detection and analyte concentration determination during continuous analyte sensing (2023-06-20),

11. 11644434 - Biosensor system analyte measurement (2023-05-09),

12. 11547330 - Apparatus and methods for probing sensor operation of continuous analyte sensing and auto-calibration (2023-01-10),

13. 11435312 - Devices using gated voltammetry methods (2022-09-06),

14. 11353417 - Risk factor monitoring (2022-06-07),

15. 11268925 - Intertwined electrical input signals (2022-03-08),

Certainly! Here is the article about the inventor Huan-Ping Wu:

Title: Innovator Spotlight: Huan-Ping Wu, Pioneering Continuous Glucose Monitoring Solutions

Introduction:

In the realm of healthcare technology innovations, inventor Huan-Ping Wu shines as a trailblazer in revolutionizing continuous glucose monitoring solutions. With a prolific number of 100 patents to his name, Wu's expertise has significantly impacted the field of analyte concentration determinations and sensor calibration methodologies.

Latest Patents:

Wu's latest patents showcase his ingenuity in enhancing the accuracy and reliability of analyte concentration determinations. One remarkable invention focuses on system error compensation during analyte analysis, introducing the concept of pseudo-reference concentration and signal-based anchor parameters to mitigate errors in biosensor measurements. Another patent delves into optimizing continuous glucose monitoring sensor calibration through a novel connection function approach, offering improved glucose value determinations for enhanced patient care.

Career Highlights:

Throughout his illustrious career, Huan-Ping Wu has made notable contributions to esteemed companies such as Ascensia Diabetes Care Holdings AG and Bayer Healthcare LLC. His dedication to advancing healthcare technology has propelled the development of cutting-edge solutions in the diabetes management sector, earning him recognition as a key innovator in the field.

Collaborations:

In his professional journey, Wu has collaborated with accomplished individuals in the industry, including Christine D. Nelson and Greg P. Beer. These collaborations have fostered a culture of innovation and knowledge sharing, leading to the successful implementation of groundbreaking projects and patents in the healthcare domain.

Conclusion:

In conclusion, Huan-Ping Wu's innovative spirit and relentless pursuit of excellence have positioned him as a visionary inventor in the realm of continuous glucose monitoring solutions. His commitment to advancing healthcare technologies underscores his significant impact on improving patient outcomes and driving transformative changes in the industry. Wu's groundbreaking patents and collaborative efforts serve as a testament to his invaluable contributions to the field of healthcare innovation.